Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

Presentation EuroPCR 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presenter: Ajay J. Kirtane, Michel Azizi

May 17, 2022

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

Presentation EuroPCR 2013

The Next Generation Renal Denervation Technology - The Vessix Device

Presenter: E. Wyffels

May 31, 2013

Presentation EuroPCR 2013

Clinical evidence in catheter-based renal sympathetic denervation - building the data

Presenter: 161082|Joachim Schofer

May 31, 2013

News Conference News

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Jason Kahn

May 18, 2011

Advertisement

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Registry Data Hint at MACE Benefit With Renal Denervation

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

The Next Generation Renal Denervation Technology - The Vessix Device

Clinical evidence in catheter-based renal sympathetic denervation - building the data

Osmolality, Viscosity Make No DIRECT Difference in Contrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content